Shingles Vaccination

SHINGRIX is a vaccine indicated for prevention of herpes zoster (HZ) (shingles):

• in adults aged 50 years and older
• in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy.

SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).

For intramuscular administration only.

Two doses (0.5 mL each) administered intramuscularly according to the following schedules:

• A first dose at Month 0 followed by a second dose administered 2 to 6 months later.

For individuals who are or will be immunodeficient or immunosuppressed and who would benefit from a shorter vaccination schedule:

• A first dose at Month 0 followed by a second dose administered 1 to 2 months later.